Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing [version 2; peer review: 2 approved]

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing [version 2; peer review: 2 approved]

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus discovered that appeared in Wuhan, China, in December 2019, causes COVID-19 disease which have resulted in cases similar to SARS-atypical pneumonia. Worldwide, around 116 million cases and 2.57 million deaths...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fabiola E Tristán-Flores, Diana Casique-Aguirre, Raquel Pliego-Arreaga, Juan A Cervantes-Montelongo, Ponciano García-Gutierrez, Gerardo Acosta-García, Guillermo A Silva-Martínez
Formato: article
Lenguaje:EN
Publicado: F1000 Research Ltd 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/cf6802b23359475da6e2f226cb976694
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares